BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21285674)

  • 1. Increased liver and spleen accumulation of Tc-99m methylene diphosphonate associated with intravenous injection of MRI contrast gadolinium-diethylenetriaminepentaacetic acid.
    Zhang W; Zhang Y; Li X; Jin Z
    Clin Nucl Med; 2011 Mar; 36(3):183-5. PubMed ID: 21285674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse hepatic and splenic uptake of Tc-99m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast.
    Shi X; Jing H; Zhuang H; Zhang Y; Jin X; Li F
    Clin Nucl Med; 2011 Mar; 36(3):178-82. PubMed ID: 21285673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast.
    Zhang W; Chen B; Deng H; Yang T; Ou X
    Clin Nucl Med; 2013 Mar; 38(3):219-20. PubMed ID: 23412599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
    Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
    Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic uptake of Tc-99m DPD on bone scintigraphy: the influence of the interval with gadolinium-containing contrast of MRI.
    Pak K; Kim SJ; Kim IJ; Suh KT
    Clin Nucl Med; 2012 Feb; 37(2):134-6. PubMed ID: 22228334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
    MacDonald J
    J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan.
    Sun SS; Tsai SC; Su CC; Kao CH
    Semin Nucl Med; 2001 Jul; 31(3):253-4. PubMed ID: 11430532
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia.
    Kekilli E; Yagmur C; Kuzucu A; Soysal O; Cikim AS; Ertem K
    Ann Nucl Med; 2004 Oct; 18(7):627-30. PubMed ID: 15586638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse liver and splenic activity with Tc-99m MDP associated with iohexol injection. A case report.
    Poulton TB; Rauchenstein JN; Murphy WD
    Clin Nucl Med; 1992 Nov; 17(11):864-5. PubMed ID: 1424374
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymmetrically increased uptake in upper extremities on (99m)Tc-MDP bone scintigraphy caused by intra-arterial injection: different uptake patterns in three cases.
    Ceylan Gunay E; Erdogan A
    Rev Esp Med Nucl; 2011; 30(6):372-5. PubMed ID: 21440333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
    Park-Holohan SJ; Blake GM; Fogelman I
    Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disassociation of splenic accumulation of Tc-99m MDP and radiocolloid.
    Spencer RP; Sziklas JJ; Zubi SM
    Clin Nucl Med; 1991 Oct; 16(10):747-9. PubMed ID: 1742928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic accumulation of Tc-99m HMDP in a patient with severe alcoholic cirrhosis of the liver.
    Kawamura E; Kawabe J; Hayashi T; Oe A; Kotani J; Torii K; Habu D; Shiomi S
    Clin Nucl Med; 2005 May; 30(5):351-2. PubMed ID: 15827413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple extraosseous accumulation of 99mTc-MDP in acute lymphocytic leukemia and reference to literature.
    Xu YH; Song HJ; Qiu ZL; Luo QY
    Hell J Nucl Med; 2010; 13(3):273-6. PubMed ID: 21193884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexplained transient splenic uptake of Tc-99m MDP in bronchogenic carcinoma.
    Sirotta P; Nelp WB
    Clin Nucl Med; 1984 Sep; 9(9):495-7. PubMed ID: 6237828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
    Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
    Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic accumulation of technetium 99m-methylene diphosphonate.
    Nisbet AP; Maisey MN
    Br J Radiol; 1982 Jun; 55(654):454-5. PubMed ID: 6213282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.